Cargando…
A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis
Clinical trial results demonstrating that B-cell depletion substantially reduces new relapses in patients with multiple sclerosis (MS) have established that B cells play a role in the pathophysiology of MS relapses. The same treatment appears not to impact antibodies directed against the central ner...
Autores principales: | Miyazaki, Yusei, Li, Rui, Rezk, Ayman, Misirliyan, Hétoum, Moore, Craig, Farooqi, Nasr, Solis, Mayra, Goiry, Lorna Galleguillos, de Faria Junior, Omar, Dang, Van Duc, Colman, David, Dhaunchak, Ajit Singh, Antel, Jack, Gommerman, Jennifer, Prat, Alexandre, Fillatreau, Simon, Bar-Or, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138149/ https://www.ncbi.nlm.nih.gov/pubmed/25136908 http://dx.doi.org/10.1371/journal.pone.0105421 |
Ejemplares similares
-
Correction: A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis
Publicado: (2014) -
Surtuin 1 as a potential prognostic biomarker in very elderly patients with colorectal cancer
por: Lee, Guk Jin, et al.
Publicado: (2021) -
Erratum: microRNA dysregulation in multiple sclerosis
por: Moore, Craig S., et al.
Publicado: (2013) -
Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis
por: Li, Rui, et al.
Publicado: (2016) -
MicroRNA dysregulation in multiple sclerosis
por: Jr, Omar de Faria, et al.
Publicado: (2013)